Renal replacement strategies: dual benefits of hydrogen gas inhalation and hydrogen-enriched dialysate.

The publication “Renal replacement strategies: dual benefits of hydrogen gas inhalation and hydrogen-enriched dialysate.” is organized in H2HUBB under the research focus hydrogen inhalation inflammation immune study 2025. The publication is cited as Ryoichi Nakazawa, Shintaro Nagami, Hirōshi Nozaki, Minako Yataka, Yoji Inada, Kazuhiro Akiyama, Takashi Uchino, Nakanobu Azuma, Medical Gas Research, 2025. This uncontrolled human study examined Renal replacement strategies: dual benefits of hydrogen gas inhalation and hydrogen-enriched dialysate. The abstract describes Human participants; sample size 11; hydrogen delivered as hydrogen inhalation and injected or infused hydrogen. The abstract reports: Emerging clinical evidence suggests that combining H2 gas inhalation and RRT using H2-enriched dialysate may enhance the management of oxidative stress and inflammation in…. This is an automated editorial draft based on the abstract and requires source review before publication.

Hydrogen inhalation inflammation immune study 2025 overview

This study aims to explore the combined effects of H2 gas inhalation and H2-enriched dialysate during HD, focusing on their potential to reduce oxidative… Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.

Study design and hydrogen intervention

Publication type: Uncontrolled human study. Evidence type: Human clinical evidence. Research model or population: Human participants. Sample size: 11. Blinding: Unknown. Control status: Unknown.

Delivery method: Hydrogen inhalation. Hydrogen concentration: 154 ppb.

Reported findings and scientific interpretation

For this hydrogen inhalation inflammation immune study 2025, the study record reports the following: The abstract reports: Emerging clinical evidence suggests that combining H2 gas inhalation and RRT using H2-enriched dialysate may enhance the management of oxidative stress and inflammation in…

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: The reported sample size was small.
Although dialysate concentrations between 100 and 400 ppb are often recommended,14 this article observed better outcomes at 300 ppb compared with 150 ppb, emphasizing…

Safety: However, further research is essential to optimize treatment protocols, ensure safety, and develop comprehensive clinical guidelines for the widespread adoption of this therapy.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.